What changed: Kaposi sarcoma
Every dated change on the records linked to Kaposi sarcoma, newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.
Approval5Guideline1Milestone8This record1
September 2026 · 1
2020 · 4
- 2020ApprovalPomalidomidePomalidomide approved in US
Kaposi sarcoma (AIDS-related after ART failure; HIV-negative)
- 2020GuidelineKaposi sarcomaGuideline ACTG A5263 (Lancet 2020): Resource-limited settings
ART plus paclitaxel where available (ACTG A5263); bleomycin-vincristine otherwise; task-shifted oncology nursing models.
- 2020MilestonePaclitaxel / nab-paclitaxelACTG A5263: paclitaxel superior to oral etoposide and bleomycin-vincristine in Africa (Lancet)
A milestone in how this cancer is treated.
- 2020MilestonePomalidomidePomalidomide approved for KS (HIV-positive and -negative)
A milestone in how this cancer is treated.